You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-Trk Receptor-ONO-7579
ONO-7579

Chemical Structure : ONO-7579

CAS No.: 1622212-25-2

ONO-7579 (ONO7579)

Catalog No.: PC-72113Not For Human Use, Lab Use Only.

ONO-7579 (ONO7579) is a novel potent, selective, orally available pan-TRK inhibitor.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

ONO-7579 (ONO7579) is a novel potent, selective, orally available pan-TRK inhibitor.
BDNF significantly increased TRKB phosphorylation in GBC cells and the effects were abrogated by ONO-7579, suppress proliferation in a dose-dependent manner in TYGBK-1 cells.
ONO-7579 inhibited BDNF/TRKB-induced migration and invasiveness, particularly in GBC cells harboring wild-type KRAS.
ONO-7579 reduced invasiveness of gallbladder cancer (GBC) cells through inhibiting epithelial–mesenchymal transition (EMT) via the extracellular signal-regulated kinase (ERK) or protein kinase B (AKT) pathway.

Physicochemical Properties

M.Wt 578.951
Formula C24H18ClF3N6O4S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Month
Shipping
Solubility

Chemical Name/SMILES

References

1. Kawamoto M, et al. Anticancer Res. 2018 Apr;38(4):1979-1986.

2. Iida H, et al. J Pharmacol Exp Ther. 2020 Jun;373(3):361-369.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: